Synapse

← Safety and Risk of Pharmacotherapy

Papers in Safety and Risk of Pharmacotherapy

Page 3 · newest first

  1. Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in KyrgyzstanSafety and Risk of Pharmacotherapy · 2021
  2. Cardiotoxic Effects of Yew Tree and Pink Periwinkle AlkaloidsSafety and Risk of Pharmacotherapy · 2021
  3. Nephrotoxicity Biomarkers: Role and Significance in the Diagnosis of Drug-Induced Kidney InjurySafety and Risk of Pharmacotherapy · 2021
  4. Investigation of Cytotoxic Effects of Recombinant Human Interferon Lambda-1 and Its Pegylated Form on Human Conjunctival Epithelial CellsSafety and Risk of Pharmacotherapy · 2021
  5. Drug-Induced Acute Kidney InjurySafety and Risk of Pharmacotherapy · 2021
  6. Analysis of Adverse Reactions in Elderly Patients Based on Quantitative Methods of Signal DetectionSafety and Risk of Pharmacotherapy · 2021
  7. Fluoroquinolone-Induced Aortic InjurySafety and Risk of Pharmacotherapy · 2021
  8. Limits for the Content of Heavy Metals and Arsenic as a Means of Ensuring Safe Use of Herbal Medicinal ProductsSafety and Risk of Pharmacotherapy · 2021
  9. Possible Causes of and Measures to Minimise Risks of Abscesses Following DTP VaccinationSafety and Risk of Pharmacotherapy · 2021
  10. Advanced Age as a Risk Factor of Drug-Induced DiseasesSafety and Risk of Pharmacotherapy · 2021
  11. Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic TreatmentSafety and Risk of Pharmacotherapy · 2021
  12. Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and RifampicinSafety and Risk of Pharmacotherapy · 2021
  13. Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs UseSafety and Risk of Pharmacotherapy · 2020
  14. Safety of Herbal Medicines: Clinical and Pharmacological AspectsSafety and Risk of Pharmacotherapy · 2020
  15. Atrial Fibrillation Associated with Anticancer DrugsSafety and Risk of Pharmacotherapy · 2020
  16. Adverse Oral Reactions Associated with Low Doses of MethotrexateSafety and Risk of Pharmacotherapy · 2020
  17. Ongoing challenges and future directions of human papillomavirus vaccinationSafety and Risk of Pharmacotherapy · 2020
  18. Drug-Induced Neutropenia and AgranulocytosisSafety and Risk of Pharmacotherapy · 2020
  19. Comparative Analysis of International Databases of Adverse Drug ReactionsSafety and Risk of Pharmacotherapy · 2020
  20. Some Aspects of Drug Induced Nephrotoxicity AssessmentSafety and Risk of Pharmacotherapy · 2020
  21. Drug-Induced Fatty Liver DiseaseSafety and Risk of Pharmacotherapy · 2020
  22. Drug-Induced Heart Failure (Part 1: The Urgency of the Problem, the Prevalence, the Effect of Certain Groups of Drugs on the Risk of Development/Progression Heart Failure)Safety and Risk of Pharmacotherapy · 2020
  23. Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor AgentsSafety and Risk of Pharmacotherapy · 2020
  24. Coronavirus disease COVID-2019Safety and Risk of Pharmacotherapy · 2020
  25. Analysis of Safety Issues of Using Statins in Patients with Diabetes and HypothyroidismSafety and Risk of Pharmacotherapy · 2019
  26. Drug-Induced EosinophiliaSafety and Risk of Pharmacotherapy · 2019
  27. Topical Issues of Drug Safety, Possibilities of Improving of PharmacovigilanceSafety and Risk of Pharmacotherapy · 2019
  28. Nanoscale Therapeutic System: Safety Assessment FeaturesSafety and Risk of Pharmacotherapy · 2019
  29. Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish MigraineursSafety and Risk of Pharmacotherapy · 2019
  30. Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacinSafety and Risk of Pharmacotherapy · 2019
  31. Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal IdentificationSafety and Risk of Pharmacotherapy · 2019
  32. Literature Monitoring for PharmacovigilanceSafety and Risk of Pharmacotherapy · 2019
  33. A Review of Cases of Development of Acute Hepatic Insufficiency Due to the Intake of Biologically Active AdditivesSafety and Risk of Pharmacotherapy · 2018
  34. Pharmacogenetics of Organic Cation TransportersSafety and Risk of Pharmacotherapy · 2018